Form 483

Merck & Co. Inc Form 483, 2015-11-19

FDA issued a Form 483 to Merck & Co. Inc on 2015-11-19 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Merck & Co. Inc · Rahway, United States · Issued November 19, 2015

Overview

  • 3 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 Nov 2015
21 CFR 312.50

General responsibilities of sponsors

Cited by Michael Serrano

19 Nov 2015
21 CFR 312.50

Ensuring compliance with plan and protocol

Cited by Michael Serrano

19 Nov 2015
21 CFR 312.57(c)

Record retention requirement

Cited by Michael Serrano

Inspected site

M&Merck & Co. IncRahway, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.50Cited across public-safe Form 483 observations2x
21 CFR 312.57(c)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere